Search hospitals > Virginia > Lynchburg
Centra Lynchburg Hematology-Oncology Clinic Inc
Claim this profileLynchburg, Virginia 24501
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
103 reported clinical trials
11 medical researchers
Summary
Centra Lynchburg Hematology-Oncology Clinic Inc is a medical facility located in Lynchburg, Virginia. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Centra Lynchburg Hematology-Oncology Clinic Inc is involved with conducting 103 clinical trials across 133 conditions. There are 11 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Erin R. Alesi, and Khalid Matin.Area of expertise
1Lung Cancer
Global LeaderStage II
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Andrew Poklepovic, MDVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Melanoma
36 reported clinical trials
85 drugs studied
Sarah W. Gordon, DOVirginia Commonwealth University/Massey Cancer Center9 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
Erin R. AlesiVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Lung Cancer
14 reported clinical trials
20 drugs studied
Khalid MatinVirginia Commonwealth University/Massey Cancer Center6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
14 reported clinical trials
30 drugs studied
Clinical Trials running at Centra Lynchburg Hematology-Oncology Clinic Inc
Lung Cancer
Breast Cancer
Multiple Myeloma
Ovarian Cancer
Melanoma
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Throat Cancer
Laryngeal Cancer
Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Biobank Collection
for Cancer
This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Centra Lynchburg Hematology-Oncology Clinic Inc?
Centra Lynchburg Hematology-Oncology Clinic Inc is a medical facility located in Lynchburg, Virginia. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Centra Lynchburg Hematology-Oncology Clinic Inc is involved with conducting 103 clinical trials across 133 conditions. There are 11 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Erin R. Alesi, and Khalid Matin.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.